Which hedge funds own CRSP? CRISPR THERAPEUTICS AG, Q2 2026 13F holders
Healthcare · Open on the interactive board
7 of the hedge funds tracked by WhaleCreep disclosed a position in CRSP (CRISPR THERAPEUTICS AG) in their Q2 2026 13F filings, worth $98.7m in total. The largest holder by portfolio weight is D. E. Shaw & Co at 0.0% of its book. 1 manager opened a new position this quarter: D. E. Shaw & Co.
7tracked managers holding
1opened this quarter
0exited this quarter
Which hedge funds hold CRSP? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| D. E. Shaw & Co | Q2 2026 | 0.0% | $48.7m | 893,812 | – | new |
| Citadel Advisors | Q2 2026 | 0.0% | $25.4m | 465,796 | -10% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $20.8m | 382,032 | 1% | added |
| Tudor Investment | Q2 2026 | 0.0% | $2.3m | 42,512 | -2% | reduced |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $679.5k | 12,459 | 121% | added |
| Horizon Kinetics | Q2 2026 | 0.0% | $510.1k | 9,353 | -5% | reduced |
| Ancora Advisors | Q2 2026 | 0.0% | $217.7k | 3,991 | -1% | reduced |
How has hedge fund ownership of CRSP changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 7 | $98.7m |
| Q1 2026 | 6 | $45.5m |
| Q4 2025 | 3 | $2.8m |
| Q3 2025 | 3 | $10.3m |
| Q2 2025 | 3 | $8.0m |
| Q1 2025 | 4 | $6.9m |
| Q4 2024 | 4 | $5.3m |
| Q3 2024 | 5 | $11.4m |
| Q2 2024 | 5 | $52.4m |
| Q1 2024 | 7 | $18.2m |
| Q4 2023 | 6 | $16.6m |
| Q3 2023 | 6 | $14.4m |
| Q2 2023 | 7 | $50.2m |
| Q1 2023 | 5 | $36.4m |
| Q4 2022 | 6 | $35.4m |
| Q3 2022 | 6 | $91.0m |
Counts every tracked manager that disclosed CRSP in that quarter's filing, including managers that have since stopped filing.